LSL Pharma Group Inc. (LSL.V)
TSXV · CAD · Healthcare · Drug Manufacturers - Specialty & Generic
CA$0.30 (-1.64%) as of
Key statistics
- Market cap
- 38.02M
- Forward P/E
- 15.00
- EPS (TTM)
- -0.0500
- Dividend yield
- 0.00%
- 52-week range
- 0.2750 – 0.5600
- Beta
- -0.40
- Revenue (TTM)
- 41.83M
- Profit margin
- -17.54%
- Analyst target
- CA$0.60
- Volume
- 25.50k
About LSL Pharma Group Inc.
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. It offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, as well as natural health products in sachets, capsules, loose powder, blister packs, and liquids for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Boucherville, QC, Canada
- Employees
- 252
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.